For example, in the face of investor pressure, pharmaceutical companies have cut their research activities dramatically, relying instead on acquisition strategies. The aim is to “de-risk” by buying up firms that have already carried out all of the costly blue skies research and have developed proven drugs.
比方说，面对投资者的压力，医药企业纷纷大幅削减研发项目，转而依靠所谓的收购战略。这样做的目的是通过收购已进行过高成本开创性研究且已开发出成熟药品的企业来实现“去风险化”。